1. Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci. 2011;1218:62-79.

https://doi.org/10.1111/j.1749-6632.2010.05835.x

PMid:21291478 PMCid:PMC4477826

2. Belfrage O, Isaksson H, Tägil M. Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats. BMC Musculoskelet Disord. 2012;13:240.

https://doi.org/10.1186/1471-2474-13-240

PMid:23217097 PMCid:PMC3528664

3. Mathavan N, Bosemark P, Isaksson H, Tägil M. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. Bone. 2013;56:440-8

https://doi.org/10.1016/j.bone.2013.06.030

PMid:23845325 

4. Bosemark P, Isaksson H, McDonald MM, Little DG. Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength. Acta Orthop. 2013;84:106-11.

https://doi.org/10.3109/17453674.2013.773123

PMid:23409846 PMCid:PMC3584593

5. Senel FC, Duman MK, Muci E, Cankaya M, Pampu AA, Ersoz S, et al. Jaw bone changes in rats after treatment with zoledronate and pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:385-91.

https://doi.org/10.1016/j.tripleo.2009.10.011

PMid:20060339 

6. Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Current Pharmaceutical Design. 2010;16:2950-60.

https://doi.org/10.2174/138161210793563635

PMid:20722616 

7. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials. 2004;25:4105-15.

https://doi.org/10.1016/j.biomaterials.2003.11.024

PMid:15046901 

8. von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials. 2005;26:6941-9.

https://doi.org/10.1016/j.biomaterials.2005.04.059

PMid:16009417 

9. Altundal H, Gursoy B. The influence of alendronate on bone formation after autogenous free bone grafting in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:285-91.

https://doi.org/10.1016/j.tripleo.2004.05.022

PMid:15716833 

10. Jakobsen T, Baas J, Bechtold JE, Elmengard B, Søballe K. Soaking morselized allograft in bisphosphonate can impair implant fixation. Clin Orthop Relat Res. 2007;463:195-201.

https://doi.org/10.1097/BLO.0b013e31813c6696

PMid:17621234 

11. Seo SW, Cho SK, Storer SK, Lee FY. Zoledronate reduces unwanted bone resorption in intercalary bone allografts. Int Orthop. 2010;34:599-603.

https://doi.org/10.1007/s00264-009-0748-7

PMid:19343345 PMCid:PMC2903128

12. Freitas NR, Lima LB, Moura MB, Veloso-Guedes CCF, Simamoto-Júnior PC, Magalhães D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21:e644-51.

PMid:27475681 PMCid:PMC5005105

13. Gelazius R, Poskevicius L, Sakavicius D, Grimuta V, Juodzbalys G. Dental Implant Placement in Patients on Bisphosphonate Therapy: A Systematic Review. J Oral Maxillofac Res. 2018;9:e2.

https://doi.org/10.5037/jomr.2018.9302

PMid:30429962 PMCid:PMC6225599

14. Chen B, Li Y, Yang X, Xu H, Xie D. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Osteoporos Int. 2013;24:2115-21.

https://doi.org/10.1007/s00198-013-2288-7

PMid:23389695 

15. Menzdorf L, Weuster M, Klüter T, Brüggemann S, Behrendt P, Fitchen-Oestern S, et al. Local Pamidronate Influences Fracture Healing in a Rodent Femur Fracture Model: An Experimental Study. BMC Musculoskelet Disord. 2016;17:255.

https://doi.org/10.1186/s12891-016-1113-9

PMid:27283180 PMCid:PMC4899908

16. Sandberg O, Bernhardsson M, Aspenberg P. Earlier Effect of Alendronate in Mouse Metaphyseal Versus Diaphyseal Bone Healing. J Orthop Res. 2017;35:793-9.

https://doi.org/10.1002/jor.23316

PMid:27233101 

17. Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of Action of Bisphosphonates: Similarities and Differences and Their Potential Influence on Clinical Efficacy. Osteoporos Int. 2008;19:733-59.

https://doi.org/10.1007/s00198-007-0540-8

PMid:18214569 

18. Toker H, Ozdemir H, Ozer H, Eren K. A comparative evaluation of the systemic and local alendronate treatment in synthetic bone graft: a histologic and histomorphometric study in a rat calvarial defect model. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:S146-52.

https://doi.org/10.1016/j.oooo.2011.09.027

PMid:23063391 

19. Vasconcelos AC, Berti-Couto SA, Azambuja AA, Salum FG, Figueiredo MA, Da Silva VD, et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. J Oral Pathol Med. 2012;41:702-12.

https://doi.org/10.1111/j.1600-0714.2012.01140.x

PMid:22417074 

20. Oliveira AL, Pedro AJ, Saiz Arroyo C, Mano JF, Rodriguez G, San Roman J, et al. Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterials. J Biomed Mater Res Appl Biomater. 2010;92:55-67.

https://doi.org/10.1002/jbm.b.31489

PMid:19701915 

21. Rosenqvist K, Airaksinen S, Fraser SJ, Gordon KC, Juppo AM. Interaction of bioactive glass with clodronate. Int J Pharm. 2013;452:102-7.

https://doi.org/10.1016/j.ijpharm.2013.04.059

PMid:23660371 

22. Välimäki VV, Moritz N, Yrjans JJ, Vuorio E, Aro HT. Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. Bone. 2006;38:432-43.

https://doi.org/10.1016/j.bone.2005.09.016

PMid:16338190 

23. Dupoirieux L, Pourquier D, Picot MC, Neves M. Comparative study of three different membranes for guided bone regeneration of rat cranial defects. Int J Oral Maxillofac Surg. 2001;30:58-62.

https://doi.org/10.1054/ijom.2000.0011

PMid:11289623 

24. Li C, Wang HR, Li XL, Zhou XG, Dong J. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir (Wien). 2012;154:731-8.

https://doi.org/10.1007/s00701-012-1283-7

PMid:22297398 

25. Manabe T, Mori S, Mashiba T, Cao Y, Kaji Y, Iwata K, et al. Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys. J Bone Miner Metab. 2009;27:295-302.

https://doi.org/10.1007/s00774-009-0046-x

PMid:19343273 

26. Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, Sato M, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res. 2002;17:2237-46.

https://doi.org/10.1359/jbmr.2002.17.12.2237

PMid:12469918 

27. Harding AK, W-Dahl A, Geijer M, Toksvig-Larsen S, Tagil M. A single bisphosphonate infusion does not accelerate fracture healing in high tibial osteotomies. Acta Orthop. 2011;82:465-70.

https://doi.org/10.3109/17453674.2011.594231

PMid:21689069 PMCid:PMC3237038

28. Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799-809.

https://doi.org/10.1056/NEJMoa074941

PMid:17878149 PMCid:PMC2324066